ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 250 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $5,650,401 | +119.2% | 347,717 | +149.4% | 0.01% | +116.7% |
| Q1 2024 | $2,578,042 | -76.4% | 139,429 | -60.0% | 0.01% | -76.0% |
| Q4 2023 | $10,918,674 | +647.4% | 348,728 | +397.5% | 0.02% | +525.0% |
| Q3 2023 | $1,460,884 | -83.4% | 70,100 | -80.9% | 0.00% | -81.8% |
| Q2 2023 | $8,784,573 | +339.5% | 366,788 | +245.4% | 0.02% | +266.7% |
| Q1 2023 | $1,998,684 | +1027.3% | 106,200 | +853.6% | 0.01% | +500.0% |
| Q4 2022 | $177,301 | -78.6% | 11,137 | -81.1% | 0.00% | -66.7% |
| Q2 2022 | $828,000 | -85.8% | 58,800 | -75.5% | 0.00% | -82.4% |
| Q1 2022 | $5,824,000 | +856.3% | 240,471 | +821.3% | 0.02% | +1600.0% |
| Q4 2021 | $609,000 | +133.3% | 26,100 | +66.2% | 0.00% | 0.0% |
| Q3 2021 | $261,000 | -22.6% | 15,700 | +13.8% | 0.00% | 0.0% |
| Q2 2021 | $337,000 | -97.6% | 13,800 | -95.2% | 0.00% | -98.6% |
| Q2 2020 | $13,892,000 | +354.3% | 286,618 | +301.0% | 0.07% | +666.7% |
| Q4 2019 | $3,058,000 | -59.4% | 71,480 | -65.9% | 0.01% | -64.0% |
| Q3 2019 | $7,540,000 | +42.0% | 209,496 | +5.5% | 0.02% | +38.9% |
| Q2 2019 | $5,309,000 | +24.9% | 198,623 | +34.8% | 0.02% | +12.5% |
| Q4 2016 | $4,250,000 | – | 147,339 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 647,833 | $26,723,000 | 11.32% |
| GREAT POINT PARTNERS LLC | 1,921,563 | $79,264,000 | 7.13% |
| Baker Brothers Advisors | 41,904,586 | $1,728,564,000 | 6.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 486,000 | $20,048,000 | 6.47% |
| Palo Alto Investors LP | 1,832,300 | $75,582,000 | 4.15% |
| Birchview Capital, LP | 204,000 | $8,416,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 556,514 | $22,956,000 | 1.97% |
| Rock Springs Capital Management LP | 1,573,200 | $64,895,000 | 1.65% |
| Riggs Asset Managment Co. Inc. | 17,470 | $2,025,000 | 0.85% |
| PFM Health Sciences, LP | 421,087 | $17,370,000 | 0.80% |